SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- Redon: Gendarmes in search of child after suspected kidnapping Nov 15, 2022
- Portal to review alimony debts is not available 5 days after its announcement Nov 23, 2022
- Arcom challenges Twitter and expresses “deep concern” over fake news and online hate Nov 21, 2022
- Australia reported that a Chinese fighter jet intercepted and attacked one of its maritime surveillance aircraft Jun 5, 2022
- StopCovid : the application should finally be ready by June 2 May 5, 2020
- Etiquette and digital protocol Jun 2, 2022
- G20, Bassi (Un.Trieste): “All-Italian technology in quantum communication” Aug 5, 2021